Your session is about to expire
← Back to Search
Mindfulness Based Cognitive Therapy for Depression (OMM Trial)
N/A
Waitlist Available
Led By Frederick Hecht, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 4 months change
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a follow-up program for people who finished a mindfulness therapy course to prevent depression from returning. It includes extra classes and regular check-ins to help them keep using their skills. The goal is to reduce the chances of depression coming back. Mindfulness-based cognitive therapy (MBCT) is a class-based program designed to prevent relapse or recurrence of major depression.
Who is the study for?
This trial is for adults over 18 in the US who have finished a Mindfulness-Based Cognitive Therapy (MBCT) program, primarily to manage depression. Participants must be able to attend virtual classes via smartphone or other devices and speak and read English.
What is being tested?
The study tests an MBCT maintenance program designed to prevent depression relapse. It includes a booster course with weekly sessions for four weeks, then monthly follow-ups focusing on mindfulness, positive emotions, reaction management, self-care, sleep, diet, and relationships.
What are the potential side effects?
As this intervention involves psychological practices rather than medication or medical procedures, side effects may include emotional discomfort or distress during mindfulness exercises but are generally considered low-risk.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 4 months change
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 4 months change
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Change in Experiences Questionnaire scores
Change in Five Facet Mindfulness Questionnaire-short form (FFMQ-sf) scores
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Depression 8a scores
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness maintenance programExperimental Treatment1 Intervention
Participants receive: (1) Four-week course to strengthen and extend skills learned in 8-week MBCT course, (2) Monthly 1.5 hour meeting session, and (3) Monthly check-in survey.
Group II: Wait-listActive Control1 Intervention
Participants receive follow-up measures but no intervention until the end of the wait-list period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness maintenance program
2023
N/A
~40
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Mindfulness-Based Cognitive Therapy (MBCT) combines mindfulness practices with cognitive behavioral techniques to help patients become more aware of their thoughts and feelings and to develop a non-judgmental attitude towards them. This enhances interoceptive awareness and helps in reducing rumination, a common feature in depression.
Cognitive Behavioral Therapy (CBT) focuses on identifying and changing negative thought patterns and behaviors, thereby improving mood and emotional regulation. Exercise and healthy lifestyle practices, such as proper diet and sleep, contribute to overall well-being by reducing stress, improving physical health, and boosting positive emotions.
These mechanisms are crucial for depression patients as they address both the psychological and physiological aspects of the disorder, promoting a holistic approach to treatment and potentially reducing the risk of relapse.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,591 Previous Clinical Trials
14,901,569 Total Patients Enrolled
73 Trials studying Depression
26,506 Patients Enrolled for Depression
Mental Insight FoundationUNKNOWN
1 Previous Clinical Trials
38 Total Patients Enrolled
1 Trials studying Depression
38 Patients Enrolled for Depression
Frederick Hecht, MDPrincipal InvestigatorUniversity of California, San Francisco
3 Previous Clinical Trials
262 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Mindfulness maintenance program
- Group 2: Wait-list
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Depression Patient Testimony for trial: Trial Name: NCT05859386 — N/A